Technical Analysis for WVE - WAVE Life Sciences Ltd.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Historical WVE trend table... |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Inside Day | Range Contraction | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% | |
Fell Below 200 DMA | Bearish | 1.07% | |
Fell Below 50 DMA | Bearish | 1.07% | |
MACD Bearish Centerline Cross | Bearish | 1.07% | |
Expansion Pivot Sell Setup | Bearish Swing Setup | 1.07% | |
Multiple of Ten Bearish | Other | 1.07% | |
Lower Bollinger Band Touch | Weakness | 1.07% | |
Fell Below 20 DMA | Bearish | -7.81% | |
Crossed Above 20 DMA | Bullish | -11.82% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time | |
---|---|---|
Down 5% | 2 days ago | |
Down 3% | 2 days ago | |
Down 2 % | 2 days ago | |
Lower Bollinger Band Support | 2 days ago | |
60 Minute Opening Range Breakdown | 2 days ago |
Free Daily (Stock) Chart Reading
- Earnings date: 11/09/2020
WAVE Life Sciences Ltd. Description
WAVE Life Sciences Pte. Ltd., a preclinical biopharmaceutical company, designs, develops, and commercializes nucleic acid therapeutic candidates. The company is developing nucleic acid therapeutics that target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. Its advanced therapeutic programs are in Huntington's disease, Duchenne muscular dystrophy (DMD), and inflammatory bowel disease (IBD). In Huntington's disease, it has programs targeting HTT SNP-1 and HTT SNP-2; in DMD, targeting Exon 51; and in IBD, targeting SMAD7. The company also has product candidates in its programs targeting HTT SNP-1 and Exon 51. In addition, it has late-stage discovery programs in epidermolysis bullosa simplex, targeting KRT14 SNP-1 and KRT14 SNP-2, as well as in DMD, focuses on an additional DMD target, AcRIIb. The company was founded in 2012 and is based in Singapore.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Acid Rare Diseases Dysfunction Medical Genetics Dystrophy Inflammatory Bowel Disease Muscular Dystrophy Huntington's Disease Ibd Genodermatoses Duchenne Muscular Dystrophy Duchenne Genetic Genealogy Epidermolysis Bullosa Cytoskeleton Dystrophin SNP
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 19.98 |
52 Week Low | 6.61 |
Average Volume | 570,323 |
200-Day Moving Average | 9.84 |
50-Day Moving Average | 9.75 |
20-Day Moving Average | 10.28 |
10-Day Moving Average | 9.80 |
Average True Range | 0.75 |
ADX | 23.35 |
+DI | 20.91 |
-DI | 22.14 |
Chandelier Exit (Long, 3 ATRs ) | 9.93 |
Chandelier Exit (Short, 3 ATRs ) | 11.09 |
Upper Bollinger Band | 11.57 |
Lower Bollinger Band | 8.99 |
Percent B (%b) | 0.17 |
BandWidth | 25.13 |
MACD Line | -0.09 |
MACD Signal Line | 0.03 |
MACD Histogram | -0.1151 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 10.54 | ||||
Resistance 3 (R3) | 10.47 | 10.03 | 10.35 | ||
Resistance 2 (R2) | 10.03 | 9.75 | 10.07 | 10.29 | |
Resistance 1 (R1) | 9.74 | 9.58 | 9.52 | 9.81 | 10.23 |
Pivot Point | 9.30 | 9.30 | 9.20 | 9.34 | 9.30 |
Support 1 (S1) | 9.01 | 9.02 | 8.79 | 9.08 | 8.65 |
Support 2 (S2) | 8.57 | 8.85 | 8.61 | 8.59 | |
Support 3 (S3) | 8.28 | 8.57 | 8.53 | ||
Support 4 (S4) | 8.35 |